Clinical trial

An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder

NCT00992407

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-12-01

PhasePHASE4

Study timeline

Study start (unknown)2007-12-01Date precision: month

Registry last updated2014-03-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Risperidone long acting injectablesDRUG

Risperidone tabletsDRUG

Sponsors & collaborators

Janssen Korea, Ltd., Korealead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00992407 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.